Medicare Plus Blue expands prior authorization program to include genetic and molecular testing

Blue Cross Blue Shield of Michigan will expand its prior authorization program with eviCore healthcare later this year to include genetic and molecular testing services for our Medicare Plus Blue^SM members who live in Michigan and use Michigan providers.

eviCore’s well-established Laboratory Management solution serves 22 clients and more than 19 million members across the nation. The expansion of prior authorization is intended to eliminate the use of certain tests that aren’t medically necessary to improve patient care and manage health care costs. Providers will need to request prior authorization for these services from eviCore.

We’ll provide more details about these changes in future issues of The Record. We’ll also announce opportunities for training on the prior authorization expansion through web-DENIS broadcast messages.